Bromfenac Solution/ Drops
Product Images NDC 65862-789

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromfenac (NDC 65862-789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel 0.09% (1.7 mL Container) (Bromfenac Fig1)

Package Label-principal Display Panel 0.09% (1.7 mL Container) (Bromfenac Fig1)
This is a description for an ophthalmic solution indicated for topical application in the eyes with the active ingredient Bromfenac. It comes in a 1.7mL bottle and has an NDC code of 65862-789-17. The concentration of Bromfenac in the solution is 0.09%. The product is manufactured by Aurobindo Pharma USA, Inc. and is only available by prescription. The item is sterile, can be used once daily, and has a specific code of TS/DRUGS/13/2010 with lot number P1410239.*
FDA Label Image

Package Label-principal Display Panel 0.09% (1.7 mL Carton) (Bromfenac Fig2)

Package Label-principal Display Panel 0.09% (1.7 mL Carton) (Bromfenac Fig2)
This is a product description for Bromfenac ophthalmic solution used for topical application in the eye before and after surgery. It contains 0.1035% bromfenac sodium, which is equivalent to 0.09% bromfenac free acid. The solution is preserved with benzalkonium chloride and contains inactive ingredients such as boric acid and polysorbate 80. The prescribed dosage is one drop into the affected eye once a day starting one day prior to surgery, on the day of surgery, and through the first 14 days post-surgery. The packaging warns to keep the product out of reach of children and instructs the patient to take precautions to avoid contamination. The solution should be kept at a temperature between 20°C to 25°C and the package should not be opened until ready to use. This product is manufactured and distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Chemical Structure (Bromfenac Str)

Chemical Structure (Bromfenac Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.